The prognostic value of peripheral hematological biomarkers in patients with hypersensitivity pneumonitis: A single-center retrospective study
Keywords:
Hypersensitivity pneumonitis (HP), systemic immune-inflammation index, aggregate index of systemic inflammation, prognostic biomarkers, interstitial lung diseasesAbstract
Background/aim: Investigating inflammation-related biomarkers in hypersensitivity pneumonitis (HP) patients may provide valuable insights, particularly in determining their clinical course and prognosis. This study aimed to explore the potential role of peripheral hematological biomarkers in predicting the clinical course and prognosis of HP patients.
Materials and methods: This retrospective study included 75 patients diagnosed with HP. Demographic data, symptoms, exposure history, pulmonary function tests, systemic immune-inflammation index (SII), and aggregate index of systemic inflammation (AISI) were analyzed.
Results: Elevated SII (1353.6±915.15) and AISI (1001.1±695.38) values were significantly higher in patients with fibrotic HP compared to non-fibrotic HP (SII: 607.84±334.53, AISI: 375.01±235.18) (p<0.001). ROC analysis showed that SII (cut-off: 644.9, AUC: 0.788) and AISI (cut-off: 438.79, AUC: 0.767) had good predictive value for fibrotic HP. For mortality, SII ≥690.12 (AUC: 0.736) and AISI ≥490.35 (AUC: 0.753) were significant predictors. These elevated values were also associated with higher mortality (46.3% vs. 8.8%, p=0.001 for SII, and 42.5% vs. 14.3%, p=0.004 for AISI). In univariate analysis, older age, digital clubbing, low FVC%, and high SII/AISI were associated with fibrotic HP, while multivariate analysis identified only increased SII (OR: 1.45, p=0.021) and reduced FVC% (OR: 0.999, p=0.043) as independent predictors.
Conclusion: SII and AISI appear as valuable prognostic tools in determining the clinical course and prognosis of HP patients. These biomarkers could be beneficial in the early diagnosis and management of HP, offering high sensitivity and specificity.
References
1. Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management. Am J Respir Crit Care Med. 2017;196(6):680-89. doi:10.1164/rccm.201611-2201PP
2. Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(3):e36-e69. doi:10.1164/rccm.202005-2032ST
3. Uzun O, Adıguzel Gundogdu B, Sullu Y, Topcu Erturk K, Kement S, Selen Ala Cıtlak F. Hypersensitivity pneumonitis in Türkiye: An underrecognized pulmonary disorder. Sarcoidosis Vasc Diffuse Lung Dis. 2025;42(2):15884. doi:10.36141/svdld.v42i2.15884
4. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi:10.1158/1078-0432.CCR-14-0442
5. Huang H, Liu Q, Zhu L, et al. Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer. Sci Rep. 2019;9(1):3284. doi:10.1038/s41598-019-39150-0
6. Kerget B, Afşin DE, Aksakal A. The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography. Sarcoidosis Vasc Diffuse Lung Dis. 2023;40(3):e2023038. doi:10.36141/svdld.v40i3.14743
7. Yang Z, Zhang J, Lu Y, et al. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget. 2015;6(40):43090-98. doi:10.18632/oncotarget.5719
8. Zinellu A, Collu C, Nasser M, et al. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis. J Clin Med. 2021;10(18):4134. doi:10.3390/jcm10184134
9. Xiu J, Lin X, Chen Q, et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front Cardiovasc Med. 2023;10:1163900. doi:10.3389/fcvm.2023.1163900
10. Song Y, Zhao Y, Shu Y, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: A cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1100453. doi:10.3389/fendo.2023.1100453
11. Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis. J Cancer. 2018;9(18):3295-302. doi:10.7150/jca.25691
12. Xie Y, Zhuang T, Ping Y, et al. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Clin Chim Acta. 2021;517:122-26. doi:10.1016/j.cca.2021.02.016
13. Koyun GB, Berk S, Dogan OT. The importance of SII and FIB-4 scores in predicting mortality in idiopathic pulmonary fibrosis patients. Clin Biochem. 2024;131-132:110789. doi:10.1016/j.clinbiochem.2024.110789
14. Ciornolutchii V, Ruta VM, Man AM, et al. Exploring the Role of Hemogram-Derived Ratios and Liver Fibrosis Scores in Pulmonary Fibrosis. Medicina (Kaunas). 2024;60(10):1702. doi:10.3390/medicina60101702
15. Mahemuti N, Jing X, Zhang N, et al. Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015-2020). Nutrients. 2023;15(5):1177. doi:10.3390/nu15051177
16. Zheng H, Yin Z, Luo X, Zhou Y, Zhang F, Guo Z. Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018. Int J Cardiol. 2024;395:131400. doi:10.1016/j.ijcard.2023.131400
17. Peng Y, Huang W, Shi Z, Chen Y, Ma J. Positive association between systemic immune-inflammatory index and mortality of cardiogenic shock. Clin Chim Acta. 2020;511:97-103. doi:10.1016/j.cca.2020.09.022
18. Kanter E, Payza U, Coşkun SM, Kaymaz E. The Prognostic Importance of the Systemic Immune Inflammation Index (SII) in Patients with Chronic Obstructive Pulmonary Disease (COPD). Journal of Current Medical Research 2023; 3(2): 43-52.
19. Ye C, Yuan L, Wu K, Shen B, Zhu C. Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study. BMC Pulm Med. 2023;23(1):295. doi:10.1186/s12890-023-02583-5
20. Kwok WC, Tam TCC, Lam DCL, Ip MSM, Ho JCM. Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severity. J Thorac Dis. 2024;16(5):2767-75. doi:10.21037/jtd-23-1392
21. Ay D, Başlılar Ş, Kulah G, Kaan Saylan B, Kalbaran Kismet G, Okutan O. Blood Cell Counts and Inflammatory Indexes in Idiopathic Pulmonary Fibrosis. Cureus. 2025;17(1):e78319. doi:10.7759/cureus.78319
22. Jiang Y, Luo B, Lu W, et al. Association Between the Aggregate Index of Systemic Inflammation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Study. J Inflamm Res. 2024;17:7057-67. doi:10.2147/JIR.S481515
23. Hosseninia S, Ghobadi H, Garjani K, Hosseini SAH, Aslani MR. Aggregate index of systemic inflammation (AISI) in admission as a reliable predictor of mortality in COPD patients with COVID-19. BMC Pulm Med. 2023;23(1):107. doi:10.1186/s12890-023-02397-5
24. Göçmen A, Gesoglu Demir T. The Aggregate Index of Systemic Inflammation as a Predictor of Mortality in Stroke Patients. Cureus. 2024;16(7):e64007. doi:10.7759/cureus.64007
25. Ercan Z, Evren Öztop K, Pınar M, et al. The aggregate index of systemic inflammation may predict mortality in COVID-19 patients with chronic renal failure. Eur Rev Med Pharmacol Sci. 2023;27(8):3747-52. doi:10.26355/eurrev_202304_32173
26. Umihanic S, Novakovic L, Alidzanovic L, et al. Prognostic Value of Systemic Immune Inflammation Index in Squamous Cell Lung Cancer. J Clin Med. 2025;14(7):2219. doi:10.3390/jcm14072219
Downloads
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
